Papers
1
Total Citations
2
H-Index
1
About
Chunlai Yu is a pioneering researcher in regenerative medicine and stem cell biology, with a focus on somatic cell reprogramming and induced pluripotent stem cell (iPSC) technology. His major contributions center on developing innovative methodologies to overcome key challenges in iPSC generation, particularly the issue of lineage manipulation during reprogramming. In his notable 2024 work, Yu introduced a robotic-based spatial-restricting structured flow system that enables the selection of monoclonal cell lineages from heterogeneous reprogramming cultures, significantly improving the purity and consistency of iPSC lines. This breakthrough addresses a critical bottleneck in producing reliable seed cells for personalized disease modeling and regenerative therapies. While his most-cited paper has garnered 2 citations, reflecting its recent publication, Yu’s work holds substantial promise for advancing clinical applications of stem cells. His research bridges engineering and biology, offering scalable solutions for high-quality iPSC production, and positions him as an emerging leader in the field.
Research Focus
Key Achievements
Top Papers
- 1